Ebola and Zika vaccine progress

As global efforts to tackle the Covid-19 infection continue, two other deadly diseases, Zika and Ebola, are also being tackled.

On 25 June, the World Health Organization announced that the world’s second-deadliest Ebola outbreak had been ended.

This was achieved using the first successful Ebola vaccine and two antibody-based drugs, all developed with research including the use of animals, monkeys in particular.

Meanwhile, at the National Institute of Allergy and Infectious Diseases (NIAID), USA, researchers have analysed two Zika vaccine candidates in monkey and mice models.

These animal studies showed that the vaccines could be effective, but not equally protective.

Zika is particularly dangerous to pregnant women due to the risk of birth defects, and such studies with animals helps to move towards preventing this risk.

Recent Posts

See All

Copyright © 2019 European Animal Research Association, All rights reserved.

European Animal Research Association 

London Office

3.04 LABS Atrium, The Stables Market, Chalk Farm Rd

London NW1 8AH
Tel: +44 (0)20 3355 3095
Email: info@eara.eu 

Brussels Office
52 Rue Marie de Bourgogne, 1st Floor
1000 Brussels,


  • Twitter
  • Facebook
  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon